We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR... Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment is developing and commercializing genome editing technology. Show more
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that three abstracts have been accepted for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.38 | -6.78571428571 | 5.6 | 5.92 | 5.11 | 1854944 | 5.48766259 | CS |
4 | -2.24 | -30.0268096515 | 7.46 | 7.52 | 5.11 | 1705735 | 6.28246999 | CS |
12 | -1.85 | -26.1669024045 | 7.07 | 11.58 | 5.11 | 1946901 | 7.87806098 | CS |
26 | -1.3 | -19.9386503067 | 6.52 | 11.69 | 5.11 | 1894905 | 8.6622235 | CS |
52 | -2.61 | -33.3333333333 | 7.83 | 11.91 | 5.11 | 1837750 | 8.66323759 | CS |
156 | -31.76 | -85.8842617631 | 36.98 | 73.025 | 5.11 | 1753116 | 18.30244681 | CS |
260 | -21.7 | -80.6092124814 | 26.92 | 99.95 | 5.11 | 1529269 | 25.58911121 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions